Proxy Governance Supports Charles River Laboratories (Massachusetts) Proposed Acquisition of WuXi PharmaTech Co., Ltd.
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that PROXY Governance, Inc., a proxy voting advisory service, recommends that Charles River shareholders vote FOR the issuance of stock to effect Charles River’s proposed acquisition of WuXi PharmaTech (NYSE: WX).